186 related articles for article (PubMed ID: 25028482)
1. Fluoxetine blocks Nav1.5 channels via a mechanism similar to that of class 1 antiarrhythmics.
Poulin H; Bruhova I; Timour Q; Theriault O; Beaulieu JM; Frassati D; Chahine M
Mol Pharmacol; 2014 Oct; 86(4):378-89. PubMed ID: 25028482
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation of Nav1.7 and Nav1.8 channels by antidepressant drugs.
Thériault O; Poulin H; Beaulieu JM; Chahine M
Eur J Pharmacol; 2015 Oct; 764():395-403. PubMed ID: 26187311
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Gating Properties and Use-Dependent Block of Nav1.5 and Nav1.7 Channels by Anti-Arrhythmics Mexiletine and Lidocaine.
Wang Y; Mi J; Lu K; Lu Y; Wang K
PLoS One; 2015; 10(6):e0128653. PubMed ID: 26068619
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of hesperetin on Nav1.5 channels stably expressed in HEK 293 cells and on the voltage-gated cardiac sodium current in human atrial myocytes.
Wang H; Wang HF; Zhang H; Wang C; Chen YF; Ma R; Xiang JZ; Du XL; Tang Q
Acta Pharmacol Sin; 2016 Dec; 37(12):1563-1573. PubMed ID: 27694909
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the cardiac Na⁺ channel α-subunit Nav1.5 by propofol and dexmedetomidine.
Stoetzer C; Reuter S; Doll T; Foadi N; Wegner F; Leffler A
Naunyn Schmiedebergs Arch Pharmacol; 2016 Mar; 389(3):315-25. PubMed ID: 26667357
[TBL] [Abstract][Full Text] [Related]
6. Differential inhibition of cardiac and neuronal Na(+) channels by the selective serotonin-norepinephrine reuptake inhibitors duloxetine and venlafaxine.
Stoetzer C; Papenberg B; Doll T; Völker M; Heineke J; Stoetzer M; Wegner F; Leffler A
Eur J Pharmacol; 2016 Jul; 783():1-10. PubMed ID: 27130441
[TBL] [Abstract][Full Text] [Related]
7. State-dependent trapping of flecainide in the cardiac sodium channel.
Ramos E; O'leary ME
J Physiol; 2004 Oct; 560(Pt 1):37-49. PubMed ID: 15272045
[TBL] [Abstract][Full Text] [Related]
8. Recombinant PaurTx-3, a spider toxin, inhibits sodium channels and decreases membrane excitability in DRG neurons.
Chen M; Peng S; Wang L; Yang L; Si Y; Zhou X; Zhang Y; Liu Z
Biochem Biophys Res Commun; 2020 Dec; 533(4):958-964. PubMed ID: 33004176
[TBL] [Abstract][Full Text] [Related]
9. The human ether-a'-go-go related gene (hERG) K+ channel blockade by the investigative selective-serotonin reuptake inhibitor CONA-437: limited dependence on S6 aromatic residues.
Alexandrou AJ; Milnes JT; Sun SZ; Fermini B; Kim SC; Jenkinson S; Leishman DJ; Witchel HJ; Hancox JC; Leaney JL
J Physiol Pharmacol; 2014 Aug; 65(4):511-23. PubMed ID: 25179083
[TBL] [Abstract][Full Text] [Related]
10. Persistent human cardiac Na+ currents in stably transfected mammalian cells: Robust expression and distinct open-channel selectivity among Class 1 antiarrhythmics.
Wang GK; Russell G; Wang SY
Channels (Austin); 2013; 7(4):263-74. PubMed ID: 23695971
[TBL] [Abstract][Full Text] [Related]
11. Reporting sodium channel activity using calcium flux: pharmacological promiscuity of cardiac Nav1.5.
Zhang H; Zou B; Du F; Xu K; Li M
Mol Pharmacol; 2015 Feb; 87(2):207-17. PubMed ID: 25422141
[TBL] [Abstract][Full Text] [Related]
12. The cardiac sodium current Na(v)1.5 is functionally expressed in rabbit bronchial smooth muscle cells.
Bradley E; Webb TI; Hollywood MA; Sergeant GP; McHale NG; Thornbury KD
Am J Physiol Cell Physiol; 2013 Aug; 305(4):C427-35. PubMed ID: 23784541
[TBL] [Abstract][Full Text] [Related]
13. Effects of norfluoxetine, the major metabolite of fluoxetine, on the cloned neuronal potassium channel Kv3.1.
Choi BH; Choi JS; Yoon SH; Rhie DJ; Min DS; Jo YH; Kim MS; Hahn SJ
Neuropharmacology; 2001 Sep; 41(4):443-53. PubMed ID: 11543764
[TBL] [Abstract][Full Text] [Related]
14. State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine.
Wang GK; Calderon J; Wang SY
Mol Pharmacol; 2008 Mar; 73(3):940-8. PubMed ID: 18079277
[TBL] [Abstract][Full Text] [Related]
15. Local-anesthetic like inhibition of the cardiac sodium channel Nav1.5 α-subunit by 5-HT3 receptor antagonists.
Van't Klooster MP; Foadi N; Hage A; Stoetzer C; Wegner F; Eberhardt M; Leffler A
Eur J Pharmacol; 2016 Oct; 789():119-126. PubMed ID: 27401036
[TBL] [Abstract][Full Text] [Related]
16. A distinct molecular mechanism by which phenytoin rescues a novel long QT 3 variant.
Gando I; Campana C; Tan RB; Cecchin F; Sobie EA; Coetzee WA
J Mol Cell Cardiol; 2020 Jul; 144():1-11. PubMed ID: 32339567
[TBL] [Abstract][Full Text] [Related]
17. Potent Inactivation-Dependent Inhibition of Adult and Neonatal NaV1.5 Channels by Lidocaine and Levobupivacaine.
Elajnaf T; Baptista-Hon DT; Hales TG
Anesth Analg; 2018 Sep; 127(3):650-660. PubMed ID: 29958221
[TBL] [Abstract][Full Text] [Related]
18. The opioid methadone induces a local anaesthetic-like inhibition of the cardiac Na⁺ channel, Na(v)1.5.
Schulze V; Stoetzer C; O'Reilly AO; Eberhardt E; Foadi N; Ahrens J; Wegner F; Lampert A; de la Roche J; Leffler A
Br J Pharmacol; 2014 Jan; 171(2):427-37. PubMed ID: 24117196
[TBL] [Abstract][Full Text] [Related]
19. Mutant voltage-gated Na
Clatot J; Zheng Y; Girardeau A; Liu H; Laurita KR; Marionneau C; Deschênes I
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1250-H1257. PubMed ID: 30118344
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine.
Kennard LE; Chumbley JR; Ranatunga KM; Armstrong SJ; Veale EL; Mathie A
Br J Pharmacol; 2005 Mar; 144(6):821-9. PubMed ID: 15685212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
